Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 18:16:1584107.
doi: 10.3389/fimmu.2025.1584107. eCollection 2025.

IgG4-related disease - focus on digestive system involvement

Affiliations
Review

IgG4-related disease - focus on digestive system involvement

Jakub Motor et al. Front Immunol. .

Abstract

IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition characterized by the infiltration of IgG4-positive plasma cells in affected tissues, leading to fibrosis and progressive organ dysfunction. This review explores the epidemiology, pathogenesis, and organ manifestations of IgG4-RD, with a focus on autoimmune pancreatitis and sclerosing cholangitis as the main clinical presentations. It may cause exocrine and endocrine pancreatic insufficiency and chronic hepatobiliary failure. Main diagnostic challenges include differentiation from malignancies and other inflammatory conditions. Diagnosis of IgG4-RD involves combination of clinical symptoms, typical imaging findings, elevated serum IgG4 levels, and histopathological evidence of IgG4-positive plasma cell infiltration. Advances in clinical understanding of the disease, histopathological and serological markers, imaging techniques, have enhanced early detection. Current treatment strategies prioritize steroids therapy for induction of remission, while steroid-sparing agents, including disease-modifying antirheumatic drugs and rituximab play the pivotal roles in managing its relapses or steroid-resistant disease. Biologic therapies are also promising therapeutic avenues. In addition, multidisciplinary approach optimizes the diagnosis, treatment, and long-term outcomes in this complex disease.

Keywords: IgG4-RD; IgG4-related cholangitis; IgG4-related disease; autoimmune disease; autoimmune pancreatitis; digestive system; steroid therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Risk factors for the development of IgG4-RD (7, 8).
Figure 2
Figure 2
EUS examination of a patient with AIP. The arrow indicates the pancreas, which exhibits a characteristic “sausage-shaped” appearance. The head and body of the pancreas are enlarged, with diffusely reduced echogenicity of the pancreatic parenchyma. The pancreatic contours are rounded.
Figure 3
Figure 3
EUS examination of a patient with AIP. The arrow indicates the pancreas, which exhibits a characteristic “sausage-shaped” appearance. The tail of the pancreas is enlarged, with diffusely reduced echogenicity of the pancreatic parenchyma. The pancreatic contours are rounded.
Figure 4
Figure 4
CT scan of a patient with AIP. The arrow points to an enlarged pancreatic head with irregular contours.
Figure 5
Figure 5
Strategy of second-line treatment in IgG4-RD (112, 121).
Figure 6
Figure 6
Summary of the therapeutic strategy in the management of IgG4-RD.

Similar articles

References

    1. Zen Y, Nakanuma Y. IgG4-related disease: A cross-sectional study of 114 cases. Am J Surg Pathol. (2010) 34. doi: 10.1097/PAS.0b013e3181f7266b - DOI - PubMed
    1. Wallace ZS, Miles G, Smolkina E, Petruski-Ivleva N, Madziva D, Cook C, et al. Incidence, prevalence and mortality of IgG4-related disease in the USA: A claims-based analysis of commercially insured adults. Ann Rheum Dis. (2023) 82:957–62. doi: 10.1136/ard-2023-223950 - DOI - PubMed
    1. AbdelRazek MA, Venna N, Stone JH. IgG4-related disease of the central and peripheral nervous systems. Lancet Neurol. (2018) 17. doi: 10.1016/S1474-4422(17)30471-4 - DOI - PubMed
    1. Della-torre E, Campochiaro C, Bozzolo EP, Dagna L, Scotti R, Nicoletti R, et al. Methotrexate for maintenance of remission in igg4-related disease. Rheumatol (United Kingdom). (2015) 54. doi: 10.1093/rheumatology/kev244 - DOI - PubMed
    1. Bledsoe JR, Della-Torre E, Rovati L, Deshpande V. IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach. APMIS. (2018) 126. doi: 10.1111/apm.12845 - DOI - PubMed

MeSH terms

LinkOut - more resources